Enhancement of Behavioral and Cognitive Outcomes in Autism Spectrum Disorder Via Neurostimulation
Completed · Not applicable · Has a placebo group
Conditions studied: Autism Spectrum Disorder
In brief
Autism spectrum disorder (ASD) encompasses a range of limitations in reciprocal social and communicative milestones, as well as restrictive and/or repetitive patterns of behavior which lead to significant functional challenges impacting individuals throughout their lifespan. There are major shortcomings in the existing pharmacological interventions; they are of limited efficacy, target a subset of problematic behaviors, and fail to improve social cognition. To overcome these limitations and improve outcomes, the investigators study the use of neurostimulation to mitigate the social and cognitive manifestations of ASD.
Key facts
- Study ID
- NCT05371912
- Run by
- Christiana Care Health Services
- People needed
- 16
- Starts
- 2022-03-15
- Expected to finish
- 2024-02-01
- Last updated by the study team
- 2025-11-26
Who can join
Age: 5 and older, up to 25. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Fulfilling the Diagnostic and Statistical Manual for Mental Disorders 5th edition (DSM-V) criteria for ASD and confirmed by Gilliam Asperger Disorder Scale (GADS)
- The patient exhibiting adequate understanding and cooperation for the procedure
You may not qualify if…
- Patients with ASD exhibiting significant anxiety or contact avoidance, precluding them from cooperating with the procedure
- Children with a known diagnosis of seizures
- Presence of any metallic implants or devices in the head or neck area
- Pregnant women
Where it is running
- Mitra Assadi — Newark, Delaware, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.